Szweda Magdalena, Szarek Józef, Dublan Krystyna, Męcik-Kronenberg Tomasz, Kiełbowicz Zdzisław, Bigoszewski Marcin
a Forensic Veterinary Medicine and Administration , University of Warmia and Mazury , Olsztyn , Poland.
Vet Q. 2014;34(4):185-93. doi: 10.1080/01652176.2014.968939. Epub 2014 Oct 20.
Non-steroidal anti-inflammatory drugs (NSAIDs) may cause gastrointestinal damage in dogs.
HYPOTHESIS/OBJECTIVES: To determine the extent to which lansoprazole, liquorice extract, and a herbal solution exhibit protective effects on colonic mucosa when administered to dogs concurrently with the NSAIDs carprofen or robenacoxib.
Thirty-five healthy beagle dogs (15 male and 20 female) aged 13-14 weeks and weighing 4.3-5.5 kg at the beginning of the experiment were included. Endoscopy and biopsy of the caudal gastrointestinal tract were performed pretreatment and on the last day of a 21-day treatment period with (1) oral carprofen; (2) carprofen and the proton-pump inhibitor lansoprazole; (3) carprofen, liquorice extract, and a herbal solution that contained extracts of thyme, icelandic lichen, hyssop, and saponariae root; (4) robenacoxib; (5) robenacoxib and lansoprazole; (6) robenacoxib, liquorice extract, and herbal solution; or (7) an empty gelatin capsule. Statistical analyses were performed with the Kruskal-Wallis, Cochran's Q, and chi-squared test with p < 0.05 considered significant.
Both carprofen and robenacoxib tested damaged the colonic mucosa with most severe microscopic lesions following administration of robenacoxib with lansoprazole. The risk of histopathological lesions in the colon increased most rapidly in robenacoxib with lansoprazole (absolute risk increase -0.85) similar to robenacoxib only (-0.75), whereas the best result was recorded following the plant remedies together with carprofen (-0.15) and the plant remedies together with robenacoxib (-0.2).
Concurrent administration of liquorice extract and an herbal solution with robenacoxib was associated with decreased severity of the NSAID-induced mucosal lesions.
非甾体抗炎药(NSAIDs)可能会对犬类造成胃肠道损伤。
假设/目的:确定兰索拉唑、甘草提取物和一种草药溶液在与NSAIDs卡洛芬或罗贝考昔同时给犬使用时,对结肠黏膜的保护作用程度。
纳入35只健康的比格犬(15只雄性和20只雌性),实验开始时年龄为13 - 14周,体重4.3 - 5.5千克。在21天的治疗期前以及最后一天,对尾段胃肠道进行内镜检查和活检,治疗分组如下:(1)口服卡洛芬;(2)卡洛芬与质子泵抑制剂兰索拉唑;(3)卡洛芬、甘草提取物以及一种含有百里香、冰岛地衣、牛膝草和皂草根提取物的草药溶液;(4)罗贝考昔;(5)罗贝考昔与兰索拉唑;(6)罗贝考昔、甘草提取物和草药溶液;或(7)空明胶胶囊。采用Kruskal - Wallis检验、Cochran's Q检验和卡方检验进行统计分析,p < 0.05认为具有显著性。
卡洛芬和罗贝考昔均检测出会损伤结肠黏膜,在罗贝考昔与兰索拉唑联合给药后出现最严重的微观病变。罗贝考昔与兰索拉唑联合使用时结肠组织病理学损伤风险增加最快(绝对风险增加 -0.85),与仅使用罗贝考昔时(-0.75)相似,而植物疗法与卡洛芬联合使用(-0.15)以及植物疗法与罗贝考昔联合使用(-0.2)时效果最佳。
甘草提取物和草药溶液与罗贝考昔联合使用可降低NSAIDs诱导的黏膜损伤严重程度。